Skip to content

Elevance Health

NYSE: ELV · USD

Elevance Health cash flow and EPS56

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$894M
Elevance Health capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q211.77% · $89M8.62% · $65.2M57.78% · $437MUnavailable21.83% · $165.1M100% · $756.3M
FY 2009 Q311.25% · $114.4M0% · $0M68.14% · $693.2MUnavailable20.61% · $209.7M100% · $1,017.3M
FY 2009 Q48.49% · $106.1M0% · $0M66.19% · $827MUnavailable25.32% · $316.4M100% · $1,249.5M
FY 2010 Q17.89% · $120.2M0.02% · $0.3M91.1% · $1,388.4MUnavailable0.99% · $15.1M100% · $1,524M
FY 2010 Q26.21% · $102.6M0% · $0M90.36% · $1,493MUnavailable3.43% · $56.7M100% · $1,652.3M
FY 2010 Q311.28% · $110.8MUnavailable47.19% · $463.7MUnavailable41.54% · $408.2M100% · $982.7M
FY 2010 Q410.38% · $117.8MUnavailable89.47% · $1,015.2MUnavailable0.15% · $1.7M100% · $1,134.7M
FY 2011 Q16.22% · $101.9M0% · $0M45.3% · $741.6M5.67% · $92.8M42.81% · $700.8M100% · $1,637.1M
FY 2011 Q211.48% · $104.7M0% · $0M78.33% · $714.7M9.98% · $91.1M0.21% · $1.9M100% · $912.4M
FY 2011 Q37.44% · $127.8M35.07% · $602.3M52.29% · $897.9M5.14% · $88.2M0.06% · $1.1M100% · $1,717.3M
FY 2011 Q419.33% · $185.1MUnavailable71.59% · $685.6M8.95% · $85.7M0.14% · $1.3M100% · $957.7M
FY 2012 Q19.89% · $123.8M0.1% · $1.2M54.32% · $679.8M7.66% · $95.8M28.03% · $350.8M100% · $1,251.4M
FY 2012 Q26.03% · $102.2M53.37% · $904.1M29.15% · $493.8M5.52% · $93.5M5.92% · $100.3M100% · $1,693.9M
FY 2012 Q38.37% · $149.1M4.88% · $87M36.77% · $655.2M5.09% · $90.7M44.9% · $800.1M100% · $1,782.1M
FY 2012 Q43.75% · $169.8M79.58% · $3,604.7M14.75% · $668M1.92% · $87.1M0% · $0.1M100% · $4,529.7M
FY 2013 Q19.62% · $107.5M0% · $0M30.43% · $340.2M10.14% · $113.4M49.81% · $556.9M100% · $1,118M
FY 2013 Q226.79% · $142MUnavailable51.94% · $275.3M21.26% · $112.7M0% · $0M100% · $530M
FY 2013 Q37.66% · $158.6MUnavailable26.81% · $554.9M5.38% · $111.4M60.15% · $1,245M100% · $2,069.9M
FY 2013 Q429.85% · $238.4M0% · $0M56.31% · $449.7M13.84% · $110.5M0% · $0M100% · $798.6M
FY 2014 Q18.78% · $135.7M0% · $0M81.68% · $1,262.8M7.98% · $123.4M1.57% · $24.2M100% · $1,546.1M
FY 2014 Q212.42% · $135.5M0% · $0M74.63% · $814.4M11.04% · $120.5M1.92% · $20.9M100% · $1,091.3M
FY 2014 Q35.53% · $139.4M0% · $0M22.93% · $578.6M4.72% · $119.2M66.82% · $1,685.7M100% · $2,522.9M
FY 2014 Q439.76% · $304M0% · $0M44.86% · $343M15.38% · $117.6MUnavailable100% · $764.6M
FY 2015 Q15.28% · $88.8M37.81% · $635.8M46.03% · $774.1M9.91% · $166.6M0.98% · $16.4M100% · $1,681.7M
FY 2015 Q24.93% · $140.9M0.2% · $5.8M22.25% · $636.5M5.73% · $163.9M66.89% · $1,913.6M100% · $2,860.7M
FY 2015 Q319.77% · $178.6MUnavailable11.65% · $105.2M18.04% · $163M50.54% · $456.5M100% · $903.3M
FY 2015 Q432.55% · $229.9M0.38% · $2.7M0% · $0M23.09% · $163.1M43.98% · $310.7M100% · $706.4M
FY 2016 Q140.77% · $117.5M0% · $0M0% · $0M59.23% · $170.7M0% · $0M100% · $288.2M
FY 2016 Q243.89% · $133.7M0% · $0M0% · $0M56.11% · $170.9M0% · $0M100% · $304.6M
FY 2016 Q349% · $164.4M0% · $0M0% · $0M51% · $171.1M0% · $0M100% · $335.5M
FY 2016 Q449.51% · $168M0% · $0M0% · $0M50.49% · $171.3M0% · $0M100% · $339.3M
FY 2017 Q117.01% · $127.9M0% · $0M6.74% · $50.7M22.9% · $172.2M53.34% · $401.1M100% · $751.9M
FY 2017 Q212.77% · $169.6M0% · $0M34.5% · $458.3M12.93% · $171.8M39.8% · $528.8M100% · $1,328.5M
FY 2017 Q314.02% · $218.7M2.17% · $33.9M72.19% · $1,126.4M11.63% · $181.4M0% · $0M100% · $1,560.4M
FY 2017 Q45.96% · $283.3M43.01% · $2,045.7M7.62% · $362.3M3.77% · $179.5M39.64% · $1,885.2M100% · $4,756M
FY 2018 Q17.76% · $218.2M47.84% · $1,346.1M14.03% · $394.7M6.82% · $191.9M23.55% · $662.7M100% · $2,813.6M
FY 2018 Q224.41% · $314.3M29.23% · $376.4M31.09% · $400.3M15.25% · $196.4M0.02% · $0.3M100% · $1,287.7M
FY 2018 Q321.07% · $355.5M0.56% · $9.5M23.53% · $397M11.56% · $195M43.27% · $730M100% · $1,687M
FY 2018 Q424.15% · $320M2.11% · $28M37.21% · $493M14.57% · $193M21.96% · $291M100% · $1,325M
FY 2019 Q129.36% · $234M0% · $0M36.89% · $294M25.85% · $206M7.9% · $63M100% · $797M
FY 2019 Q224.69% · $221M0% · $0M51.17% · $458M23.02% · $206M1.12% · $10M100% · $895M
FY 2019 Q313.76% · $271M0% · $0M32.71% · $644M10.36% · $204M43.17% · $850M100% · $1,969M
FY 2019 Q433.18% · $351M0% · $0M28.83% · $305M19.09% · $202M18.9% · $200M100% · $1,058M
FY 2020 Q16.96% · $204M65.05% · $1,908M18.04% · $529M8.18% · $240M1.77% · $52M100% · $2,933M
FY 2020 Q236.81% · $233MUnavailable8.69% · $55M38.23% · $242M16.27% · $103M100% · $633M
FY 2020 Q314.05% · $306M3.08% · $67M34.8% · $758M10.93% · $238M37.14% · $809M100% · $2,178M
FY 2020 Q49.79% · $278M0.11% · $3M47.8% · $1,358M8.24% · $234M34.07% · $968M100% · $2,841M
FY 2021 Q121.36% · $204M2.83% · $27M46.81% · $447M29.01% · $277M0% · $0M100% · $955M
FY 2021 Q25.27% · $285M63.12% · $3,415M8.87% · $480M5.14% · $278M17.6% · $952M100% · $5,410M
FY 2021 Q326.14% · $258M0% · $0M45.69% · $451M27.96% · $276M0.2% · $2M100% · $987M
FY 2021 Q426.5% · $340M2.65% · $34M40.69% · $522M21.28% · $273M8.89% · $114M100% · $1,283M
FY 2022 Q121.47% · $254M5.16% · $61M46.07% · $545M26.12% · $309M1.18% · $14M100% · $1,183M
FY 2022 Q210.91% · $295M20.26% · $548M23.07% · $624M11.42% · $309M34.34% · $929M100% · $2,705M
FY 2022 Q324.54% · $305M1.13% · $14M46.58% · $579M24.62% · $306M3.14% · $39M100% · $1,243M
FY 2022 Q414.1% · $298M1.23% · $26M26.87% · $568M14.43% · $305M43.38% · $917M100% · $2,114M
FY 2023 Q16.24% · $301M33.98% · $1,638M12.9% · $622M7.28% · $351M39.59% · $1,908M100% · $4,820M
FY 2023 Q225.75% · $350M0.96% · $13M47.53% · $646M25.75% · $350M0% · $0M100% · $1,359M
FY 2023 Q327.81% · $319MUnavailable41.85% · $480M30.34% · $348M0% · $0M100% · $1,147M
FY 2023 Q420.36% · $326MUnavailable57.96% · $928M21.61% · $346M0.06% · $1M100% · $1,601M
FY 2024 Q111.9% · $279M47.78% · $1,120M24.15% · $566M16.17% · $379M0% · $0M100% · $2,344M
FY 2024 Q227.65% · $323M0.34% · $4M39.64% · $463M32.36% · $378M0% · $0M100% · $1,168M
FY 2024 Q321.15% · $332M0% · $0M3.82% · $60M24.08% · $378M50.96% · $800M100% · $1,570M
FY 2024 Q44.57% · $322M52.34% · $3,685M25.72% · $1,811M5.3% · $373M12.07% · $850M100% · $7,041M
FY 2025 Q17.23% · $196MUnavailable32.45% · $880M14.23% · $386M46.09% · $1,250M100% · $2,712M
FY 2025 Q225.92% · $267MUnavailable36.7% · $378M37.38% · $385M0% · $0M100% · $1,030M
FY 2025 Q314.3% · $360MUnavailable34.8% · $876M15.14% · $381M35.76% · $900M100% · $2,517M
FY 2025 Q425.68% · $293MUnavailable41.28% · $471M33.04% · $377MUnavailable100% · $1,141M
FY 2026 Q19.46% · $235MUnavailable45.23% · $1,124M15.13% · $376M30.18% · $750M100% · $2,485M
FY 2026 Q232.1% · $287M0% · $0M26.17% · $234M41.72% · $373M0% · $0M100% · $894M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$1,913M

Capital expenditures

USD millions

$287M

Free cash flow

USD millions

$1,626M

Stock-based compensation

USD millions

$75M

SBC / free cash flow

% · FCF before SBC deduction

4.61%

SBC / operating cash flow

%

3.92%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$6.71

Quarterly data

Elevance Health cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20261,9132871,626754.61%3.92%—$6.71
FY 2026 Q1Mar 31, 20264,3322354,097551.34%1.27%—$8
FY 2025 Q4Dec 31, 202584293-20930—35.71%——
FY 2025 Q3Sep 30, 20251,1353607758410.84%7.4%—$5.32
FY 2025 Q2Jun 30, 20252,0542671,787814.53%3.94%—$7.72
FY 2025 Q1Mar 31, 20251,017196821819.87%7.96%—$9.61
FY 2024 Q4Dec 31, 2024706322384-29-7.55%-4.11%——
FY 2024 Q3Sep 30, 20242,6773322,345662.81%2.47%—$4.36
FY 2024 Q2Jun 30, 20244473231249274.19%20.58%—$9.85
FY 2024 Q1Mar 31, 20241,9782791,699623.65%3.13%—$9.59
FY 2023 Q4Dec 31, 2023-2,971326-3,29772————
FY 2023 Q3Sep 30, 20232,6133192,294783.4%2.99%—$5.45
FY 2023 Q2Jun 30, 20231,9503501,600784.88%4%—$7.79
FY 2023 Q1Mar 31, 20236,4693016,168610.99%0.94%—$8.3
FY 2022 Q4Dec 31, 2022-1,518298-1,81673————
FY 2022 Q3Sep 30, 20224,9243054,619691.49%1.4%—$6.68
FY 2022 Q2Jun 30, 20222,4522952,157723.34%2.94%—$6.79
FY 2022 Q1Mar 31, 20222,5412542,287502.19%1.97%—$7.39
FY 2021 Q4Dec 31, 20211,6723401,332594.43%3.53%——
FY 2021 Q3Sep 30, 20212,5042582,246632.8%2.52%—$6.13
FY 2021 Q2Jun 30, 20211,6832851,398694.94%4.1%—$7.25
FY 2021 Q1Mar 31, 20212,5052042,301642.78%2.55%—$6.71
FY 2020 Q4Dec 31, 20203,8132783,535691.95%1.81%—$2.19
FY 2020 Q3Sep 30, 2020-1,150306-1,45680———$0.87
FY 2020 Q2Jun 30, 20205,5102335,277671.27%1.22%—$8.91
FY 2020 Q1Mar 31, 20202,5152042,311672.9%2.66%—$5.94
FY 2019 Q4Dec 31, 20191,327351976686.97%5.12%—$3.62
FY 2019 Q3Sep 30, 20191,6672711,396866.16%5.16%—$4.55
FY 2019 Q2Jun 30, 20191,4372211,216705.76%4.87%—$4.36
FY 2019 Q1Mar 31, 20191,6302341,396705.01%4.29%—$5.91
FY 2018 Q4Dec 31, 20184633201439163.64%19.65%—$1.61
FY 2018 Q3Sep 30, 2018606.9355.5251.456.922.63%9.38%—$3.62
FY 2018 Q2Jun 30, 2018542.2314.3227.935.915.75%6.62%—$3.98
FY 2018 Q1Mar 31, 20182,214.9218.21,996.742.22.11%1.91%—$4.99
FY 2017 Q4Dec 31, 2017-1,301.2283.3-1,584.538.9———$4.67
FY 2017 Q3Sep 30, 20172,404.7218.72,18643.61.99%1.81%—$2.8
FY 2017 Q2Jun 30, 2017393.1169.6223.544.419.87%11.29%—$3.16
FY 2017 Q1Mar 31, 20172,688.2127.92,560.342.71.67%1.59%—$3.73
FY 2016 Q4Dec 31, 2016274.7168106.740.337.77%14.67%—$1.37
FY 2016 Q3Sep 30, 2016963.5164.4799.141.95.24%4.35%—$2.3
FY 2016 Q2Jun 30, 2016662133.7528.344.88.48%6.77%—$2.91
FY 2016 Q1Mar 31, 20161,304.3117.51,186.837.63.17%2.88%—$2.63
FY 2015 Q4Dec 31, 2015949.1229.9719.237.25.17%3.92%—$0.68
FY 2015 Q3Sep 30, 2015343.4178.6164.842.425.73%12.35%—$2.43
FY 2015 Q2Jun 30, 20151,173140.91,032.141.54.02%3.54%—$3.13
FY 2015 Q1Mar 31, 20151,650.588.81,561.727.11.74%1.64%—$3.09
FY 2014 Q4Dec 31, 2014305.13041.143.23,927.27%14.16%—$1.8
FY 2014 Q3Sep 30, 2014605.7139.4466.336.87.89%6.08%—$2.22
FY 2014 Q2Jun 30, 20141,071135.5935.550.15.36%4.68%—$2.56
FY 2014 Q1Mar 31, 20141,387.5135.71,251.838.83.1%2.8%—$2.4
FY 2013 Q4Dec 31, 2013272.8238.434.442.3122.97%15.51%—$0.49
FY 2013 Q3Sep 30, 20131,397.4158.61,238.840.63.28%2.91%—$2.16
FY 2013 Q2Jun 30, 2013425.2142283.241.614.69%9.78%—$2.64
FY 2013 Q1Mar 31, 2013956.9107.5849.421.52.53%2.25%—$2.89
FY 2012 Q4Dec 31, 2012759.8169.859022.83.86%3%—$1.51
FY 2012 Q3Sep 30, 2012240.2149.191.152.257.3%21.73%—$2.15
FY 2012 Q2Jun 30, 2012521.5102.2419.3399.3%7.48%—$1.94
FY 2012 Q1Mar 31, 20121,223.1123.81,099.332.52.96%2.66%—$2.53
FY 2011 Q4Dec 31, 201157.9185.1-127.236.7—63.39%—$0.96
FY 2011 Q3Sep 30, 20111,429.8127.81,30237.22.86%2.6%—$1.9
FY 2011 Q2Jun 30, 2011771.8104.7667.138.35.74%4.96%—$1.89
FY 2011 Q1Mar 31, 20111,114.9101.91,01322.62.23%2.03%—$2.44
FY 2010 Q4Dec 31, 2010587117.8469.239.48.4%6.71%—$1.4
FY 2010 Q3Sep 30, 2010896.5110.8785.739.55.03%4.41%—$1.84
FY 2010 Q2Jun 30, 2010256.1102.6153.54328.01%16.79%—$1.71
FY 2010 Q1Mar 31, 2010-322.9120.2-443.114.1———$1.96
FY 2009 Q4Dec 31, 200929.7106.1-76.437.9—127.61%—$5.95
FY 2009 Q3Sep 30, 20091,439.6114.41,325.2392.94%2.71%—$1.53
FY 2009 Q2Jun 30, 2009377.689288.651.917.98%13.74%—$1.43
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · ELV, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.